Improving Expression of Pepsinogen A from Homo sapiens in Aspergillus niger by Using a Multi-Copy Gene Knock-in Strategy

Jie Chen, Ling Gui, Bo‐Yu Chen, Yuang Sun, Yongcan Zhao, Fuping Lu, Ming LiFermentation 2023 · DOI

TL;DR

This paper tackles the challenge of producing human pepsinogen A (hPGA) for therapeutic use by engineering the fungus Aspergillus niger. They developed a novel multi-copy gene knock-in strategy using CRISPR/Cas9, achieving a record-breaking enzyme activity of 542.3 U/mL, significantly improving upon previous methods and paving the way for cost-effective microbial production.

What Problem Does This Paper Address?

Human pepsinogen A (hPGA) is a crucial protein for diagnosing and treating gastrointestinal diseases. Currently, the primary source of hPGA is extraction from pig stomachs, which is limited in supply and prohibitively expensive. This scarcity and cost hinder its widespread application. The authors propose a more sustainable and economical solution: producing hPGA through microbial fermentation using an engineered strain. However, achieving high yields of recombinant proteins in microbial hosts like Aspergillus niger is a persistent challenge. Previous attempts to express hPGA or its porcine counterpart in bacteria and yeast yielded very low amounts. This paper aims to overcome these limitations by developing a robust system for high-level hPGA expression in A. niger.

Methods

The core of this research lies in a sophisticated genetic engineering approach using the CRISPR/Cas9 system for precise genome editing in Aspergillus niger.

  • Codon Optimization: The human hPGA5 gene sequence was first optimized to match the codon usage bias of A. niger, a standard practice to enhance translation efficiency in a heterologous host.
  • Expression Cassette Construction: The optimized hPGA5 gene was then fused with a strong promoter (Pglucan703) and a signal peptide (from the Talaromyces emersonii glucoamylase gene) to facilitate extracellular secretion.
  • CRISPR/Cas9 Mediated Multi-Copy Gene Knock-in: This is the key innovation. Instead of random integration, the researchers employed a CRISPR/Cas9 system to precisely insert multiple copies of the hPGA5 expression cassette into specific, pre-selected "safe harbor" loci within the A. niger genome. They targeted genes involved in neutral amylase, glucoamylase, and several alpha-glucosidase pathways (amyA, glaA, agdA-G). The system allowed for the simultaneous editing of multiple genes, enabling the creation of strains with varying numbers of hPGA5 copies (from one to four) integrated at different locations.
  • Transformation and Screening: A. niger protoplasts were transformed with the CRISPR/Cas9 plasmids and donor DNA fragments. Transformants were screened using PCR to confirm successful integration at the intended loci and to determine the copy number of the integrated hPGA5 gene.
  • Fermentation and Enzyme Activity Assay: Promising strains were cultured in shake flasks, and the extracellular hPGA enzyme activity was measured using a modified hemoglobin-based assay. This assay quantifies the amount of TCA-soluble products formed by pepsin's proteolytic activity.

Datasets

Not discussed in the paper. The study relies on the Aspergillus niger 41683 strain and its genome, with specific genes identified as integration targets.

Key Insights and Ideas

  • Integration Site Matters (A Lot!): The study strongly emphasizes that the chromosomal integration site of the hPGA5 gene significantly impacts expression levels. Certain native gene loci (like amyA, agdA, agdF, and agdB) proved to be highly favorable for hPGA expression, leading to much higher enzyme activities compared to others (e.g., glaA). This highlights the importance of selecting appropriate "safe harbor" sites for heterologous protein expression.
  • Multi-Copy Integration is Beneficial, But Not Always Linear: While increasing the copy number of the hPGA5 gene generally led to higher expression, the relationship wasn't strictly linear. Strains with two copies often outperformed those with three or four copies. This suggests that exceeding a certain copy number might trigger cellular stress responses (like ER-associated degradation or unfolded protein response) that limit further increases in protein production.
  • CRISPR/Cas9 as a Powerful Tool for Strain Engineering: The research demonstrates the efficacy of the CRISPR/Cas9 system for precise, marker-free, and multi-copy gene integration in A. niger. This allows for systematic optimization of expression by controlling both the number of gene copies and their genomic location.
  • Record-Breaking hPGA Activity: The ultimate success of the strategy is the achievement of an unprecedented enzyme activity for recombinant hPGA, significantly surpassing previous reports.

Key Results

  • Free Expression: Initial attempts at free expression of hPGA in A. niger yielded low enzyme activity (maximum 109.4 U/mL). SDS-PAGE confirmed low-level protein expression.
  • Integrated Expression: Integration of the hPGA5 cassette into the A. niger genome led to substantially higher enzyme activities.
  • Optimal Integration Sites: Strains with single-copy integration at specific loci like agdF (An_2-2) achieved the highest activity of 542.3 U/mL. Other favorable sites included agdB (An_2-10), amyA(12) (An_1-5), and agdA (An_2-1), yielding activities of 516.5, 497.8, and 436.9 U/mL, respectively.
  • Multi-Copy Impact: Strains with two copies of hPGA5, particularly at the agdE and agdF sites (An_2-8), showed high activity (531.3 U/mL). While strains with three and four copies were constructed, their expression levels were not consistently higher than optimal two-copy strains.
  • Highest Activity: The strain An_2-2, with a single copy of hPGA5 integrated at the agdF locus, achieved the highest recorded enzyme activity of 542.3 U/mL after 7 days of shake-flask fermentation.

Limitations and Future Work

  • Optimization of Multi-Copy Strains: The authors note that the highest expression was not always achieved with the highest copy numbers. They suggest that further investigation into the mechanisms limiting protein expression at higher copy numbers (e.g., ERAD, UPR) is needed.
  • Scale-Up: While shake-flask fermentation demonstrated high activity, the study does not detail scale-up to industrial bioreactors, which would be the next logical step for practical production.
  • Further Integration Site Exploration: Although several promising integration sites were identified, exploring additional loci within the A. niger genome could potentially lead to even higher expression levels.
  • Protein Purification and Characterization: While enzyme activity was measured, detailed characterization of the purified recombinant hPGA (e.g., its biochemical properties, stability) is not presented.

Summary updated

Abstract

Pepsinogen A (PGA) plays an important role in the treatment of human gastrointestinal diseases. At present, PGA is mainly extracted from pig stomach, so its source is very limited and its price is very expensive. Production of PGA by microbial fermentation using an engineered strain with high PGA yield would be an ideal solution. This paper presents a new system for the high-level expression of PGA from Homo sapiens (hPGA) in Aspergillus niger. The hPGA5 gene codon was optimized according to the codon bias of A. niger and then connected to a strong promoter and signal peptide to construct an hPGA5 expression cassette. An ingenious multi-copy knock-in expression strategy mediated by the CRISPR/Cas9 tool was used to improve the production of hPGA in A. niger. By optimizing the copy number and integration sites of the hPGA5 gene, an engineering strain with a high yield of hPGA was constructed. After shake-flask fermentation for 7 d, the enzyme activity of recombinant hPGA reached 542.3 U/mL, which is the highest known activity. This lays a foundation for the production of hPGA by microbial fermentation.
BibTeX
@inproceedings{chen2023improving,
  author = {Jie Chen and Ling Gui and Bo‐Yu Chen and Yuang Sun and Yongcan Zhao and Fuping Lu and Ming Li},
  title = {{Improving Expression of Pepsinogen A from Homo sapiens in Aspergillus niger by Using a Multi-Copy Gene Knock-in Strategy}},
  booktitle = {Fermentation},
  year = {2023},
  doi = {10.3390/fermentation9060538},
}
Figure